Molecules 2019, 24, 4154
15 of 19
Dimethyl 2-hydroxy-6-methyl-2H-benzo[b][1,4]oxazine-2,3-dicarboxylate (4a): Recrystallised from
1
hexane-ethyl acetate (1:1) to yield an orange solid. Yield: 59%, 154 mg. H NMR (400 MHz; d6-DMSO)
8.66 (1H, s, OH) 7.43 (1H, m, Aryl-H), 7.27 (1H, dd, J 8.0, 2.0 Aryl-H), 7.00 (1H, d, J 8.34, Aryl-H),
3.80 (6H, d, J 11.2, O-CH3), 2.32 (3H, s, O-CH3). 13C NMR (100 MHz; d6-DMSO) 167.4 (C=O), 162.3
(C=O), 148.9 (q-C), 142.5 (q-C), 132.6 (Aryl-CH), 130.8 (Aryl-C), 128.8 (Aryl-CH), 127.0 (Aryl-C), 119.0
(Aryl-CH), 89.7 (Aryl-C), 53.7 (O-CH3), 53.5 (O-CH3). LC-MS m/z 278.8 ([M
+ H]+, 78). HR-MS calculated for C13H14NO6 280.0816, found 280.0820 (
0.4 ppm, mDa
(neat)
max/cm−1 3164 (br, w, O-H), 2963 (w, C-H) 1764 (s, C=O), 1723 (s, C=O), 1439 (m, N-O), 1229 (s,
N-O) 1129 (s, N-O), 1056 (s, C-O). Crystal data: CCDC 1957010, C13H13O6N, f.w. 279.24, T = 100 K,
−
H]−, 100%), 280.8 ([M
0.4). IR
−
−
υ
monoclinic, a = 5.861(6), b = 14.109(15), c = 7.528(8) Å,
β
= 90.70(3)◦, V = 622.5(11) Å3, space group Pc
(no. 7), Z = 2, pseudo-merohedral twinning by a 180◦ rotation around z axis, 3986 reflections (2028
unique, Rint = 0.111), R1 = 0.147, wR2 = 0.390. M.p = 207.2–207.8 ◦C.
Dimethyl 6-chloro-2-hydroxy-2H-benzo[b] [1,4]oxazine-2,3-dicarboxylate (4b): Recrystallised from
1
hexane-ethyl acetate (1:1) to yield a yellow solid. Yield 19%, 142 mg. H NMR (400 MHz; CDCl3) 7.51
(1H, m, Aryl-H), 7.22 (1H, dd, J 8.0, 2.0, Aryl-H), 6.94 (1H, d, J 8.34, Aryl-H), 5.13 (1H, s, O-H), 3.97 (6H,
d, J 11.2, O-CH3). 13C NMR (100 MHz; DMSO) 167.0 (C=O), 162.3 (C=O), 148.9 (q-C), 142.5 (q-C), 132.6
(Aryl-CH), 130.8 (Aryl-C), 128.8 (Aryl-CH), 127.0 (Aryl-C), 119.0 (Aryl-CH), 89.7 (Aryl-C), 53.7 (O-CH3),
53.5 (O-CH3). LC-MS m/z (300.3 [M + H]+, 100%), 302.3 ([M + H]+ (37Cl), 25). HR-MS calculated
for C12H11NO635Cl 300.0273 found: 300.0274 (
−
0.3 ppm, mDa 0.1). IR (neat) υ
max/cm−1 3189 (w, br,
−
O-H), 2963 (w, C-H) 1768 (s, C=O), 1725 (s, C=O), 1439 (m, N-O), 1152 (s, N-O), 1000 (s, C-O). Crystal
data: CCDC 1957004, C12H10O6NCl, f.w. 299.66, T = 120 K, monoclinic, a = 5.8201(12), b = 7.5030(15),
c = 14.348(3) Å,
β
= 90.784(8)◦, V = 626.5(2) Å3, space group P21 (no. 4), Z = 2, pseudo-merohedral
twinning by a 180◦ rotation around x axis, 7346 reflections (2831 unique, Rint = 0.043), R1 = 0.085, wR2
= 0.224. M.p = 217.4–219.0 ◦C.
Dimethyl 6-bromo-2-hydroxy-2H-benzo[b] [1,4]oxazine-2,3-dicarboxylate (4c): Recrystallised from
1
hexane-ethyl acetate (1:1) to yield a cream solid. Yield 10%, 86 mg. H NMR (400 MHz; d6-DMSO)
8.79 (1H, s, O-H), 7.86 (1H, d, J 2.4, Aryl-H), 7.64 (1H, dd, J 8.8, 2.4 Aryl-H), 7.13 (1H, d, J 8.8, Aryl-H),
3.86 (3H, s, J 11.2, O-CH3), 3.77 (3H, s, O-CH3). 13C NMR (100 MHz; d6-DMSO) 167.0 (C=O), 162.3
(C=O), 148.9 (q-C), 142.9 (q-C), 135.4 (Aryl-CH), 131.7 (Aryl-C-H), 131.2 (Aryl-C), 119.5 (Aryl-C-H),
114.5 (Aryl-C), 89.7 (Aryl-C), 53.8 (O-CH3), 53.6 (O-CH3). LC-MS: m/z 346.3 ([M + H]+ (81Br), 52%),
344.6 ([M
ppm, mDa
1439 (m, N-O), 1152 (s, N-O), 1000 (s, C-O). M.p, = 220.9–222.7 ◦C.
−
H]− (81Br), 100). HR-MS calculated for C12H11NO679Br 343.9770, found 343.9757. (
1.3). IR (neat)
max/cm−1 3189 (w, br, O-H), 2963 (w, C-H) 1768 (s, C=O), 1725 (s, C=O),
−
3.8
−
υ
Dimethyl 6-formyl-2-hydroxy-8-methoxy-2H-benzo[b] [1,4]oxazine-2,3-dicarboxylate
Recrystallised from hexane-ethyl acetate (7:3) to yield a cream solid. Yield 45%, 190 mg. 1H
NMR (400 MHz, DMSO-d6) 9.96 (s, 1H, ROC-H), 9.19 (s, 1H, O-H), 7.86 (d, J = 1.8 Hz, 1H, Aryl-H),
7.61 (d, J = 1.8 Hz, 1H, Aryl-H), 3.93 (s, 3H, O-CH3), 3.87 (s, 3H, O-CH3), 3.79 (s, 3H, O-CH3). 13C NMR
(101 MHz, DMSO-d6) 191.68 (CHO), 166.76 (C=O), 162.31 (C=O), 149.1, 148.5, 138.4, 131.2 (2C), 130.1,
125.2 (Aryl-CH), 112.8 (Aryl-CH), 56.6 (O-CH3), 53.9 (O-CH3), 53.7 (O-CH3). LC-MS: m/z 324.4 ([M +
H]+, 100%), 322.2 ([M H]−, 100). HR-MS calculated for C14H11NO679Br 322.0563, found 322.0569.
(+1.9 ppm, mDa +0.6). IR (neat)
max/cm−1 2964 (w, C-H), 1765 (s, C=O), 1724 (s, C=O), 1601 (w, N-H),
1485 (m), 1284 (s) 1132 (s, C-O), 975 (s), 799 (s) 584 (m). Crystal data: CCDC 1963155, C14H13O8N, f.w.
323.25, T = 100 K, monoclinic, a = 5.8339(14), b = 10.095(3), c = 12.653(3) Å, = 103.773(5), = 91.131(5),
= 96.467(5)◦, V = 718.4(3) Å3, space group P
(no. 2), Z = 2, 6906 reflections (2896 unique, Rint
0.057), R1 = 0.064, wR2 = 0.195. M.p, = 212.0–213.8 ◦C.
(4d):
δ
δ
−
υ
α
β
γ
1
=
Dimethyl 7-methoxy-2-hydroxy-2H-benzo[b][1,4]oxazine-2,3-dicarboxylate (4i): Recrystallised from
1
hexane-ethyl acetate (3:2) to yield a white solid. Yield 30%, 109 mg. H NMR (400 MHz, DMSO)
δ 8.68
(s, 1H, O-H), 7.53 (s, 1H, Ar-H), 6.76 (Aryl-H), 6.69 (Aryl-H), 3.81 (s, 3H, O-CH3), 3.76 (s, 3H, O-CH3),